Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’
Open Access
- 22 October 2019
- journal article
- review article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. X (X), 1-13
- https://doi.org/10.14218/JCTH.2019.00034
Abstract
Liver cirrhosis progresses through multiple clinical stages which culminate in either death or liver transplantation. Availability of organs, timely listing and prompt receipt of donor-livers pose difficulties in improving transplant-listed and transplant outcomes. In this regard, regenerative therapies, particularly with granulocyte colony-stimulating factor (GCSF), has become a lucrative option for improving transplant-free survival. However, the literature is confusing with regards to patient selection and real outcomes. In this exhaustive review, we describe the basics of liver fibrosis and cirrhosis through novel insights from a therapeutic point of view, discuss preclinical studies on GCSF in advanced liver disease to improve on clinical utility, shed light on the pertinent literature of GCSF in advanced cirrhosis, and provide astute inputs on growth factor therapy in decompensated cirrhosis.Keywords
This publication has 64 references indexed in Scilit:
- Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled TrialPLOS ONE, 2013
- Loss of c-Met accelerates development of liver fibrosis in response to CCl4 exposure through deregulation of multiple molecular pathwaysBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosisJournal of Hepatology, 2012
- Cell Signals Influencing Hepatic FibrosisInternational Journal of Hepatology, 2012
- Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shockAmerican Journal of Health-System Pharmacy, 2010
- Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver FibrosisPLOS ONE, 2010
- Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathwaysJournal of Hepatology, 2009
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsProceedings of the National Academy of Sciences of the United States of America, 2009
- Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: A randomized trialJournal of Hepatology, 2008
- A Ribosomal S-6 Kinase–Mediated Signal to C/EBP-β Is Critical for the Development of Liver FibrosisPLOS ONE, 2007